GHRH 5mg

GHRH Research Overview

Growth Hormone Releasing Hormone (GHRH) is a naturally occurring peptide hormone responsible for stimulating growth hormone secretion from the anterior pituitary gland.

In laboratory research environments, GHRH is studied for its role in endocrine signaling pathways, receptor-mediated hormone regulation, and peptide-driven signal transduction mechanisms.

The 5mg research format is suitable for controlled laboratory experiments, receptor-binding studies, endocrine pathway analysis, and academic research applications.

Scientific Background of GHRH

GHRH plays a central role in the hypothalamic–pituitary axis, regulating the release of growth hormone through receptor activation in pituitary cells.

Researchers study GHRH to understand hormone signaling cascades, receptor activation mechanisms, and endocrine feedback regulation.

Because of its well-defined biological function, GHRH is widely used in endocrine research models investigating hormone-driven cellular responses.

Synthetic GHRH enables controlled laboratory experiments analyzing hormone signaling pathways without therapeutic or clinical application.

Mechanistic Research Perspective

• Growth hormone release pathway investigation
• Pituitary receptor activation and signaling analysis
• Endocrine feedback mechanism research
• Signal transduction pathway modulation studies
• Hormone–receptor interaction and downstream response investigation

Primary Research Applications

Endocrine Signaling Research: GHRH is widely used to investigate hormonal signaling pathways regulating growth hormone release and endocrine system communication.

Receptor-Binding Studies: Researchers apply GHRH in receptor-binding assays to examine activation of GHRH receptors and downstream intracellular signaling.

Cellular Pathway Analysis: GHRH supports studies analyzing second-messenger signaling pathways and gene expression responses triggered by peptide hormones.

Hormone Interaction Research: Laboratories investigate how GHRH interacts with other endocrine regulators within the hypothalamic–pituitary signaling network.

In-Vitro Endocrine Research Models: European research institutions incorporate GHRH into controlled in-vitro models to study endocrine regulation and hormone signaling mechanisms.

Molecular Characteristics

• Molecular Type: Hypothalamic peptide hormone
• CAS Identifier: 9034-39-3
• Molecular Formula: C215H358N72O66S
• Structure: Polypeptide hormone
• Form: Lyophilized peptide powder

Stability Profile and Storage Recommendations

• Store lyophilized peptide at −20°C for long-term stability
• Protect from moisture and light exposure
• Avoid repeated freeze–thaw cycles
• Reconstituted solutions should be refrigerated
• Handle using sterile laboratory procedures

Solubility and Reconstitution Options

• Sterile bacteriostatic water
• Sterile saline solutions
• Buffered aqueous laboratory solutions
• Biochemical assay buffers
• Laboratory-grade solvent systems

Technical Specifications

Analytical Validation and Quality Assurance

• High-performance liquid chromatography (HPLC) purity verification
• Mass spectrometry molecular weight confirmation
• Peptide structural integrity analysis
• Batch-to-batch consistency validation
• Stability and peptide integrity testing

Regulatory and Compliance Statement

GHRH 5mg supplied by BioPeptide is intended strictly for laboratory research use only. It is not approved for human consumption, veterinary use, therapeutic treatment, cosmetic application, or diagnostic purposes. Buyers must ensure compliance with applicable research regulations and institutional policies.

Frequently Asked Questions